ASHPOfficial

In this episode of the Pharmacy Leaders series podcast, host, Sara White, MS, FASHP, along with Kimberly Boler BS, CPhT, CSPT, DPLA, and Sam Calabrese MBA, FASHP discusses the role of pharmacy technicians as leaders. This podcast explores whether leaders are born or made and the non-negotiable qualities of a successful leader.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician

Harm reduction is a public health strategy designed to reduce the adverse consequences associated with drug and alcohol use. The goal for providers is to work with individuals to minimize the harmful effects of drug use and to promote safer use in a compassionate, non-judgmental manner.  Dr. Courtenay Wilson will discuss evidence-based strategies to reduce harm for individuals that abuse drugs and alcohol. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Interdisciplinary rounding teams are a common occurrence within health-systems.  In this podcast, listeners will hear from a medical resident and a medical student about their experiences on working on an interdisciplinary team and discuss their appreciation for the pharmacy team.  

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast series will highlight the recommended approach to managing patients with peripheral arterial disease from screening to therapy selection. Appropriate risk factor modification and therapy is essential in PAD to optimize care by reducing cardiovascular morbidly and mortality.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The COVID-19 pandemic has required pharmacist preceptors to rethink how to deliver APPE and resident rotations within our health systems.  This podcast will explain a successful model implemented within an ambulatory care setting. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will focus on leading through rapid change as a result of Covid-19. The main topics include change within various pharmacy services, including hospital closures, mergers and acquisitions, restructuring pharmacist responsibilities and modification or elimination of current pharmacy services. In addition to discussing changes, this podcast will discuss lessons learned, opportunities that arose and efforts to reactivate services that were discontinued. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join our content matter experts from the 2020 Midyear Clinical Meeting as they identify optimization strategies for pain and sedation medication management in mechanically ventilated COVID-19 patients, describe the patient-specific considerations when optimizing pain and sedation management affected by drug shortages and discuss patient-specific challenges associated with medication shortages for COVID-19 patients requiring mechanical ventilation.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

With the increased use of direct-activity oral anticoagulants (DOACs) over the last decade, it is inevitable that emergency departments are seeing more patients with DOAC-related bleeding. Get an inside look at pharmacists’ strategies for optimizing reversal of DOAC-related bleeding in various ED settings.

To learn more about this initiative, visit www.ashpadvantage.com/stopdoacbleed

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast series will highlight the recommended approach to managing patients with peripheral arterial disease from screening to therapy selection. Appropriate risk factor modification and therapy is essential in PAD to optimize care by reducing cardiovascular morbidly and mortality.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Janet Mighty, Dawn Moore, and Christy Norman will share their insights on their professional journeys as pharmacists, association leaders, and African-American women. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.